Blood culture

Lore & Background

Procedures for culturing the blood were published as early as the mid-19th century, but these techniques were labour-intensive and bore little resemblance to contemporary methods. Detection of microbial growth involved visual examination of the culture bottles until automated blood culture systems, which monitor gases produced by microbial metabolism, were introduced in the 1970s. In developed countries, manual blood culture methods have largely been made obsolete by automated systems. To perform the test, blood is drawn into bottles containing a liquid formula that enhances microbial growth, called a culture medium. Usually, two containers are collected during one draw, one designed for aerobic organisms and one for anaerobic organisms. Two sets of blood cultures are sometimes collected from two different blood draw sites. If an organism only appears in one of the two sets, it is more likely to represent contamination with skin flora than a true bloodstream infection. The containers are placed in an incubator for several days to allow the organisms to multiply. If microbial growth is detected, a Gram stain is conducted from the culture bottle to confirm that organisms are present and provide preliminary information about their identity. The blood is then subcultured onto an agar plate to isolate microbial colonies for full identification and antimicrobial susceptibility testing. Rapid testing methods have been developed using technologies like polymerase chain reaction and MALDI-TOF MS.

Reader's Guide

Blood culture is a cornerstone of diagnosing bloodstream infections, which can lead to sepsis, a life-threatening condition. Its significance lies in its ability to identify the causative microorganism and determine antimicrobial susceptibility, enabling targeted therapy. The test helps distinguish true infection from contamination by comparing results from multiple sets drawn from different sites. False negative results can occur if the sample is collected after antimicrobial drugs are given or if bottles are underfilled. Some organisms require special techniques for detection. The epidemiology of bloodstream infections varies with time and place; for instance, Gram-positive organisms overtook Gram-negative organisms as the predominant cause of bacteremia in the United States during the 1980s and 1990s, and rates of fungemia have increased with immunosuppressive treatments. In Africa, Salmonella enterica is a leading cause of bacteremia. The introduction of automated blood culture systems in the 1970s revolutionized the field, replacing labour-intensive manual methods in developed countries. Despite advances, challenges remain in low- and middle-income countries where pre-formulated culture bottles can be prohibitively expensive.

Did You Know?

• Blood culture bottles contain an anticoagulant, sodium polyanethol sulfonate (SPS), which does not interfere with the growth of most organisms.
• Two sets of blood cultures are sometimes collected from two different blood draw sites to help distinguish contamination from true infection.
• Automated blood culture systems, which monitor gases produced by microbial metabolism, were introduced in the 1970s.
• Coagulase-negative staphylococci (CNS) are commonly encountered in blood cultures, but it is often unclear whether they are true pathogens or contaminants.

Defining the Condition and Its Immediate Dangers

Hemoptysis refers to the passage of blood or blood-tinged mucus out through the mouth, originating from the bronchi, larynx, trachea, or lungs. It is fundamentally airway bleeding and does not always present with a cough. The condition can arise from lung cancers, infections like tuberculosis, bronchiectasis, or pneumonia, as well as certain cardiovascular issues. The critical risk in massive cases is not hemorrhagic shock but rather airway obstruction—the patient can choke on their own blood. Given that the total capacity of the tracheal and bronchial lumen is roughly 150 cc, a threshold around 200 mL makes physiological sense as the point where fatal asphyxiation becomes a realistic threat.

The Diagnostic Workup

Evaluating hemoptysis begins with a thorough clinical history, including prior diagnoses of tuberculosis, bronchiectasis, chronic bronchitis, or mitral stenosis, as well as occupational exposures to silica dust and smoking history. The clinician must distinguish whether blood is truly coughed up from the airways or vomited from the gastrointestinal tract. Observing the character of the mucus—whether it is blood-streaked, frothy and pink, fresh and bright red, or dark and coffee-colored—helps localize the source. Imaging plays a central role: chest X-rays, CT scans with 3D reconstruction, CT virtual bronchoscopy, and bronchial angiography can pinpoint the bleeding site. Laboratory work includes complete blood counts, sputum cell and bacterial examinations, and sputum culture. Bronchial fiber endoscopy provides direct visualization and can confirm the origin of hemorrhage.

A Spectrum of Causes

The etiology of hemoptysis spans an extraordinary range. In adults, the most frequent culprits are chest infections such as bronchitis and pneumonia, while in children a foreign body lodged in the airway is a leading cause. Lung cancers—both non-small cell and small cell carcinoma—and tuberculosis round out the common list. Less frequent causes include aspergilloma, bronchiectasis, coccidioidomycosis, pulmonary embolism, pneumonic plague, and cystic fibrosis. At the rarer end sit hereditary hemorrhagic telangiectasia, Goodpasture's syndrome, and granulomatosis with polyangiitis. In women, thoracic endometriosis can produce intermittent hemoptysis synchronized with menstrual cycles, affecting roughly 7% of those with thoracic endometriosis syndrome. Anticoagulant overuse, particularly warfarin, can precipitate or worsen episodes. Misdiagnosis is a real hazard: blood-tinged mucus from the sinuses or nose, or even extensive non-respiratory trauma, can be mistaken for true airway bleeding.

Treatment Strategies and Mortality

Managing hemoptysis is tailored to its underlying cause. Immediate measures include iced saline irrigation and topical vasoconstrictors like adrenaline or vasopressin applied to the bleeding site. Tranexamic acid has demonstrated a reduction in in-hospital mortality. Selective bronchial intubation can collapse the affected lung to isolate hemorrhage, while endobronchial tamponade offers mechanical pressure. During bronchoscopy, laser photocoagulation can cauterize the bleeding vessel. Bronchial artery angiography both localizes the source and enables embolization; in fact, bronchial artery embolization is now regarded as the first-line interventional treatment. Surgery—lobectomy or even pneumonectomy—remains the last resort. Cough suppressants are contraindicated because they elevate choking risk. Despite advances, mortality among hospitalized hemoptysis patients stands at approximately 9.4%, though some reports cite fatality rates as high as 80% in the most severe presentations.